Literature DB >> 19494275

Fc receptor-like 3 protein expressed on IL-2 nonresponsive subset of human regulatory T cells.

Satoshi Nagata1, Tomoko Ise, Ira Pastan.   

Abstract

Fc receptor-like 3 (FCRL3) is a cell surface protein homologous to Fc receptors. The FCRL3 gene is present in humans but not in mice. We found that FCRL3 protein is expressed on 40% of human naturally occurring CD4(+) regulatory T (nTreg) cells (CD4(+)CD25(+)CD127(low)). Sorted nTreg cells with the surface phenotype FCRL3(+) and FCRL3(-) were both hypoproliferative to TCR stimulation and both suppressive on proliferation of conventional T cells (CD4(+)CD25(-)) in vitro. They both expressed forkhead box p3 (Foxp3) protein, the intracellular regulatory T cell marker. However, in contrast to FCRL3(-) nTreg cells, FCRL3(+) nTreg cells were not stimulated to proliferate by the addition of exogenous IL-2. In addition, Foxp3(+) cells induced from conventional T cells by TGF-beta treatment did not exhibit FCRL3 expression. These results suggest that the FCRL3(+) subset of human nTreg cells identified in this study arise in vivo and Foxp3 expression alone is not sufficient to induce FCRL3 expression. FCRL3 may be involved in human-specific mechanisms to control the generation of nTreg cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19494275      PMCID: PMC2745186          DOI: 10.4049/jimmunol.0802230

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  51 in total

1.  Interpreting flow cytometry data: a guide for the perplexed.

Authors:  Leonore A Herzenberg; James Tung; Wayne A Moore; Leonard A Herzenberg; David R Parks
Journal:  Nat Immunol       Date:  2006-07       Impact factor: 25.606

Review 2.  The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells.

Authors:  Ethan M Shevach; Richard A DiPaolo; John Andersson; Dong-Mei Zhao; Geoffrey L Stephens; Angela M Thornton
Journal:  Immunol Rev       Date:  2006-08       Impact factor: 12.988

3.  Human CD4+ regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells.

Authors:  Dennis J Hartigan-O'Connor; Chungkee Poon; Elizabeth Sinclair; Joseph M McCune
Journal:  J Immunol Methods       Date:  2006-11-03       Impact factor: 2.303

Review 4.  Role of TCR specificity in CD4+ CD25+ regulatory T-cell selection.

Authors:  Cristina Cozzo Picca; Joseph Larkin; Alina Boesteanu; Melissa A Lerman; Andrew L Rankin; Andrew J Caton
Journal:  Immunol Rev       Date:  2006-08       Impact factor: 12.988

5.  Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells.

Authors:  Jun Wang; Andreea Ioan-Facsinay; Ellen I H van der Voort; Tom W J Huizinga; René E M Toes
Journal:  Eur J Immunol       Date:  2007-01       Impact factor: 5.532

Review 6.  The GITR-GITRL interaction: co-stimulation or contrasuppression of regulatory activity?

Authors:  Ethan M Shevach; Geoffrey L Stephens
Journal:  Nat Rev Immunol       Date:  2006-08       Impact factor: 53.106

7.  Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells.

Authors:  Ye Zheng; Steven Z Josefowicz; Arnold Kas; Tin-Tin Chu; Marc A Gavin; Alexander Y Rudensky
Journal:  Nature       Date:  2007-01-21       Impact factor: 49.962

8.  Foxp3 occupancy and regulation of key target genes during T-cell stimulation.

Authors:  Alexander Marson; Karsten Kretschmer; Garrett M Frampton; Elizabeth S Jacobsen; Julia K Polansky; Kenzie D MacIsaac; Stuart S Levine; Ernest Fraenkel; Harald von Boehmer; Richard A Young
Journal:  Nature       Date:  2007-01-21       Impact factor: 49.962

9.  Expression pattern of the human FcRH/IRTA receptors in normal tissue and in B-chronic lymphocytic leukemia.

Authors:  Andrew G Polson; Bing Zheng; Kristi Elkins; Wesley Chang; Changchun Du; Patrick Dowd; Lulu Yen; Christine Tan; Jo-Anne Hongo; Hartmut Koeppen; Allen Ebens
Journal:  Int Immunol       Date:  2006-07-18       Impact factor: 4.823

10.  Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells.

Authors:  Nabila Seddiki; Brigitte Santner-Nanan; Jeff Martinson; John Zaunders; Sarah Sasson; Alan Landay; Michael Solomon; Warwick Selby; Stephen I Alexander; Ralph Nanan; Anthony Kelleher; Barbara Fazekas de St Groth
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

View more
  23 in total

Review 1.  Emerging roles for the FCRL family members in lymphocyte biology and disease.

Authors:  F J Li; W J Won; E J Becker; J L Easlick; E M Tabengwa; R Li; M Shakhmatov; K Honjo; P D Burrows; R S Davis
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

2.  CD21(-/low) marginal zone B cells highly express Fc receptor-like 5 protein and are killed by anti-Fc receptor-like 5 immunotoxins in hepatitis C virus-associated mixed cryoglobulinemia vasculitis.

Authors:  Benjamin Terrier; Satoshi Nagata; Tomoko Ise; Michelle Rosenzwajg; Ira Pastan; David Klatzmann; David Saadoun; Patrice Cacoub
Journal:  Arthritis Rheumatol       Date:  2014-02       Impact factor: 10.995

3.  A functional variant in FCRL3 is associated with higher Fc receptor-like 3 expression on T cell subsets and rheumatoid arthritis disease activity.

Authors:  Urmila D Bajpai; Louise A Swainson; Jeff E Mold; Jonathan D Graf; John B Imboden; Joseph M McCune
Journal:  Arthritis Rheum       Date:  2012-08

Review 4.  Treg cells in rheumatoid arthritis: an update.

Authors:  Faye A H Cooles; John D Isaacs; Amy E Anderson
Journal:  Curr Rheumatol Rep       Date:  2013-09       Impact factor: 4.592

5.  FCRL3 promotes TLR9-induced B-cell activation and suppresses plasma cell differentiation.

Authors:  Fu Jun Li; Daniel M Schreeder; Ran Li; Jiongru Wu; Randall S Davis
Journal:  Eur J Immunol       Date:  2013-08-12       Impact factor: 5.532

6.  Combination therapy with anti-CTLA-4 and anti-PD-1 leads to distinct immunologic changes in vivo.

Authors:  Rituparna Das; Rakesh Verma; Mario Sznol; Chandra Sekhar Boddupalli; Scott N Gettinger; Harriet Kluger; Margaret Callahan; Jedd D Wolchok; Ruth Halaban; Madhav V Dhodapkar; Kavita M Dhodapkar
Journal:  J Immunol       Date:  2014-12-24       Impact factor: 5.422

7.  CD164 identifies CD4+ T cells highly expressing genes associated with malignancy in Sézary syndrome: the Sézary signature genes, FCRL3, Tox, and miR-214.

Authors:  Bernice M Benoit; Neha Jariwala; Geraldine O'Connor; Landon K Oetjen; Timothy M Whelan; Adrienne Werth; Andrea B Troxel; Hélène Sicard; Lisa Zhu; Christopher Miller; Junko Takeshita; Daniel W McVicar; Brian S Kim; Alain H Rook; Maria Wysocka
Journal:  Arch Dermatol Res       Date:  2016-10-20       Impact factor: 3.017

8.  Expression of the autoimmune susceptibility gene FcRL3 on human regulatory T cells is associated with dysfunction and high levels of programmed cell death-1.

Authors:  Louise A Swainson; Jeff E Mold; Urmila D Bajpai; Joseph M McCune
Journal:  J Immunol       Date:  2010-02-26       Impact factor: 5.422

9.  Cutting edge: human FcRL4 and FcRL5 are receptors for IgA and IgG.

Authors:  Timothy J Wilson; Anja Fuchs; Marco Colonna
Journal:  J Immunol       Date:  2012-04-09       Impact factor: 5.422

10.  Coexpression of TIGIT and FCRL3 identifies Helios+ human memory regulatory T cells.

Authors:  Khalid Bin Dhuban; Eva d'Hennezel; Emil Nashi; Amit Bar-Or; Sadiye Rieder; Ethan M Shevach; Satoshi Nagata; Ciriaco A Piccirillo
Journal:  J Immunol       Date:  2015-03-11       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.